GlassScriptPhysician profile
Ahmad Iqbal
NPI 1174753917
$94,523.82
in general payments reported to CMS, 2019-2025
29 companies · $15K in 2025
The $15K reported for 2025 was more than what 80% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $6,606 · 2021: $23K · 2022: $22K · 2023: $14K · 2024: $15K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Food and Beverage: $4,687 · Travel and Lodging: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,785.00 |
| Food and Beverage | $4,686.57 |
| Travel and Lodging | $377.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $43,665.03 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $31,752.24 | 2020-2025 | Jardiance |
| Pfizer INC. | $8,736.85 | 2019-2025 | |
| Abbott Laboratories | $6,398.87 | 2019-2025 | Cardiomems, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $1,046.55 | 2019-2024 | Watchman Flx, Watchman Access System, Bodyguardian |
| Novartis Pharmaceuticals Corporation | $665.94 | 2021-2025 | |
| Biotronik INC. | $316.58 | 2020-2022 | |
| Atricure, INC. | $273.82 | 2021 | |
| Abiomed | $234.33 | 2024-2025 | Impella |
| Amgen INC. | $219.21 | 2020-2024 | Repatha |
| Impulse Dynamics (USA) INC. | $168.57 | 2023-2025 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $145.40 | 2021-2023 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $142.20 | 2025 | |
| Cvrx, INC. | $105.15 | 2021-2023 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $97.26 | 2020-2023 | Eliquis |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $85.36 | 2020-2023 | Onpattro |
| Janssen Pharmaceuticals, INC | $70.85 | 2022-2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $63.06 | 2021-2023 | Opsumit, Uptravi |
| United Therapeutics Corporation | $60.38 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $45.65 | 2020-2022 | |
| Novo Nordisk INC | $35.09 | 2021-2024 | Ozempic, Rybelsus |
| Inari Medical, INC. | $29.96 | 2022 | |
| Baxter Healthcare | $29.87 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Akcea Therapeutics, INC. | $28.51 | 2021 | |
| Shockwave Medical, INC | $24.38 | 2022 | |
| Biosense Webster, INC. | $23.32 | 2024 | Na |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.38 | 2023-2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $19.78 | 2024 | Arcalyst |
| Medtronic, INC. | $17.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.